BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12427058)

  • 1. Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma.
    Harbour JW; Ahmad S; El-Bash M
    Arch Ophthalmol; 2002 Nov; 120(11):1463-9. PubMed ID: 12427058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
    Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
    Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid exudation following plaque radiotherapy for posterior uveal melanoma.
    Mills MD; Harbour JW
    Am J Ophthalmol; 2006 Mar; 141(3):594-595. PubMed ID: 16490526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhegmatogenous retinal detachment in eyes with uveal melanoma.
    Haimovici R; Mukai S; Schachat AP; Haynie GD; Thomas MA; Meredith TA; Gragoudas ES
    Retina; 1996; 16(6):488-96. PubMed ID: 9002131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
    Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
    Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
    Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
    Correa ZM; Huth B; Augsburger JJ
    Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
    McCannel TA; McCannel CA
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive plaque radiotherapy after local resection of uveal melanoma.
    Damato B
    Front Radiat Ther Oncol; 1997; 30():123-32. PubMed ID: 9205892
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma.
    Beykin G; Pe'er J; Hemo Y; Frenkel S; Chowers I
    Br J Ophthalmol; 2013 Dec; 97(12):1534-7. PubMed ID: 24064939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas.
    Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
    Ophthalmology; 2002 Oct; 109(10):1855-61. PubMed ID: 12359606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
    PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of exudative retinal detachment in choroidal melanoma.
    Gibran SK; Kapoor KG
    Clin Exp Ophthalmol; 2009 Sep; 37(7):654-9. PubMed ID: 19788660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of exudative retinal detachment after plaque therapy for intraocular melanoma.
    Radtke ND; Augsburger JJ; Schmitt T
    Am J Ophthalmol; 1991 Jul; 112(1):92-4. PubMed ID: 1882929
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.